Sign Out
Pregnancy: Apart from epidural administration for obstetrical use, there are no adequate data on the use of ropivacaine in human pregnancy. Experimental animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see Pharmacology: Toxicology: Pre-Clinical Safety Data under Actions).
Spinal administration in caesarean section has not been documented.
Lactation: It is not known whether ropivacaine passes into breast milk.
